Eton Pharmaceuticals, Inc. SEC filings ETON
Eton Pharmaceuticals, Inc. has 422 filings in SEC EDGAR's recent list, going back to Jun 28, 2017. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Jan 27, 2026 | — |
| CORRESP | Letter to the SEC | Jan 14, 2026 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2025 | — |
| EFFECT | Filing | May 2, 2023 | — |
| CORRESP | Letter to the SEC | May 1, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 12, 2023 | — |
| NT 10-Q | Filing | Nov 16, 2021 | Sep 30, 2021 |
| EFFECT | Filing | Aug 25, 2020 | — |
| CORRESP | Letter to the SEC | Aug 24, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 4, 2020 | — |
| UPLOAD | Letter from the SEC | May 27, 2020 | — |
| CORRESP | Letter to the SEC | May 15, 2020 | — |
| UPLOAD | Letter from the SEC | May 5, 2020 | — |
| D | Filing | Apr 8, 2020 | — |
| EFFECT | Filing | Dec 16, 2019 | — |
| CORRESP | Letter to the SEC | Dec 12, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 10, 2019 | — |
| EFFECT | Filing | Nov 9, 2018 | — |
| CT ORDER | Filing | Nov 9, 2018 | — |
| CERT | Filing | Nov 8, 2018 | — |
| 8-A12B | Filing | Nov 8, 2018 | — |
| DRS/A | Filing | Jun 28, 2018 | — |
| DRS | Filing | Mar 20, 2018 | — |
| D | Filing | Jun 28, 2017 | — |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ETON (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Deer Park, IL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1710340
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.